The research findings primarily focus on individuals with a sleep disorder but may have broader implications. A recent study ...
CervoMed's Phase 2b study extension shows improved cognitive outcomes with neflamapimod, leading to an analyst upgrade and ...
This unexpected early warning sign relates to a change in sensory perception, specifically your sense of smell. A declining ...
2don MSN
For people with a certain sleep disorder, a simple blood test could help predict the development of dementia years before ...
CervoMed has announced positive results from the extension phase 2b RewinD-LB study of neflamapimod for dementia with Lewy ...
For people with a certain sleep disorder, a simple blood test could help predict the development of dementia years before symptoms appear, a new study indicates. Idiopathic REM sleep behavior disorder ...
Researchers at McGill University found that a blood test originally designed for Alzheimer’s can predict dementia risk in ...
A new batch of neflamapimod capsules led to increased plasma drug concentrations and demonstrated improvement (p<0.001 vs. old capsules; ...
Hospice use varies depending on whether a person has Parkinson’s disease, Lewy body dementia or Alzheimer’s disease and those with Parkinson’s may have more unmet needs, a new study finds.
“Project Preserve has demonstrated exceptional foresight and dedication in educating students about brain health and dementia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results